NCT06546995 - Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 9, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions

Alzheimer's DiseaseHealthy Elderly

Interventions

DRUG

NMRA-323511

Participants will receive NMRA-323511 orally.

DRUG

Placebo

Participants will receive matching placebo tablets orally.

Trial Locations (26)

11229

RECRUITING

Neumora Investigator Site, Brooklyn

13057

COMPLETED

Neumora Investigator Site, East Syracuse

28204

RECRUITING

Neumora Investigator Site, Charlotte

30318

RECRUITING

Neumora Investigator Site, Atlanta

32127

RECRUITING

Neumora Investigator Site, Port Orange

32807

RECRUITING

Neumora Investigator Site, Orlando

33009

RECRUITING

Neumora Investigator Site, Hallandale

33016

RECRUITING

Neumora Investigator Site, Hialeah

33024

RECRUITING

Neumora Investigator Site, Pembroke Pines

33126

RECRUITING

Neumora Investigator Site, Miami

33137

RECRUITING

Neumora Investigator Site, Miami

33155

RECRUITING

Neumora Investigator Site, Miami

33166

RECRUITING

Neumora Investigator Site, Miami Springs

33467

RECRUITING

Neumora Investigator Site, Greenacres City

34205

RECRUITING

Neumora Investigator Site, Bradenton

48085

RECRUITING

Neumora Investigator Site, Troy

75149

RECRUITING

Neumora Investigator Site, Mesquite

83704

RECRUITING

Neumora Investigator Site, Boise

85283

ACTIVE_NOT_RECRUITING

Neumora Investigator Site, Tempe

85286

RECRUITING

Neumora Investigator Site, Chandler

90717

RECRUITING

Neumora Investigator Site, Lomita

92626

COMPLETED

Neumora Investigator Site, Costa Mesa

94596

COMPLETED

Neumora Investigator Site, Walnut Creek

96817

RECRUITING

Neumora Investigator Site, Honolulu

02478

RECRUITING

Neumora Investigator Site, Belmont

08755

RECRUITING

Neumora Investigator Site, Toms River